BackHistogen Overview

Histogen Current Cash

Histogen's current cash is $4.6M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$4.57M
↓ 68.57% YoYΔ $-9.98M vs prior year quarter

Peer trimmed avg / median

Loading

Histogen Current Cash History

Loading

Histogen vs. peers: Current Cash Comparison

Loading

Histogen Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Histogen (HSTO) FAQ

Histogen (HSTO) currently reports a current cash of $4.6M as of September 2023. That compares with $15M in the prior-year period — down 68.6% year over year. Use the charts on this page to explore Histogen's current cash history and peer comparisons.

Histogen's current cash decreased from $15M to $4.6M — a 68.6% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Histogen reported $4.6M in current cash as of September 2023. That compares with $15M in the prior-year period — down 68.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $4.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Histogen, and consider following HSTO for alerts when major investors trade the stock.

Histogen is classified in the Healthcare sector. On current cash, it currently shows $4.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HSTO with unrelated industries.